BlackRock, Inc. 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Purchase | 2025-03-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 9,042,979 7.500% | 2,546,386 (+39.20%) | Filing |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 6,496,593 8.800% | 1,210,419 (+22.90%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 5,286,174 8.000% | 1,988,694 (+60.31%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 3,297,480 7.000% | 1,268,223 (+62.50%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 2,029,257 5.400% | 2,029,257 (New Position) | Filing |